Oncofusion

start / graph / ana-cxxc-dna-affinity-ladder

Analysisstrong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.Q82-cxxc-affinity

The CXXC-DNA affinity is a ten-point ladder from 44 uM to 33 nM, not two numbers 1,300-fold apart, and every step but the last is under 5.5-fold

also called 44 uM versus 33 nM · CXXC affinity discrepancy · MT domain affinity reconciliation

Two published numbers for how tightly the fusion's CpG-gripping module holds DNA differ 1,300-fold, and this project built an argument on the weaker one. Reading the six primary papers shows they are not in conflict: there are ten measurements forming a smooth ladder, and only the final step - the one this beat could not resolve - is large.

The same thing, for a scientist

This project repeatedly argued that the CXXC-DNA contact is too weak to hold the fusion on chromatin, on the basis of Kd 44 uM (Cierpicki 2010, NMR titration, Q03164 1147-1203, 300 mM NaCl, a 12-bp palindrome with one CpG). Birke 2002 reports KD 3.28 +/- 1.7 x 10^-8 M by SPR for GST-MT (Q03164 1147-1244) on a 52-bp six-CpG duplex at 150 mM NaCl. Reading both plus Allen 2006, Erfurth 2008, Liang 2021 and Risner 2013 in full yields ten measurements of the same contact spanning 44 uM to 33 nM. Sorted by affinity, every adjacent step is 5.5-fold or smaller except the final one, which is 19-fold and is the only unresolved step. Three pairs isolate variables. Cierpicki 44 uM against Liang 5.7 uM - both tagless, both a 12-bp single-CpG palindrome - differ only in ionic strength (300 against 150 mM NaCl) and method, and differ 7.7-fold, which is the closest thing to a direct measurement of the salt term. Erfurth 3.5 uM against Risner 0.64 uM - same laboratory, same 1147-1203 span, the SAME oligonucleotide - differ 5.5-fold across GST tag plus the same salt drop, which bounds the GST-avidity explanation far below what it was being asked to carry. Erfurth CpG3A-I 32 uM against CpG1-I 3.5 uM - same construct, same salt, same method - differ 9-fold on DNA sequence alone. Erfurth 2008 noted the discrepancy in print in 2008 and offered the GST-bivalency explanation; that paper is cited nowhere else in this graph. The residual 19-fold between Risner and Birke confounds four variables and is unresolved.

Go deeper
The ten measurements, sorted by affinity
#sourceKMT2A constructtagmethodDNA ligandmonovalent saltKd
1Cierpicki 2010 11147-1203 (57 aa)none (15N)NMR chemical-shift titration, solution equilibriumDNA-pal CCCTGCGCAGGG, 12 bp, 1 CpG300 mM NaCl, 50 mM phosphate pH 7.1, 25 C44 uM
2Erfurth 2008 21147-1203 (57 aa)GST cleaved off with thrombinITC, solution equilibriumCpG3A-I TGCCGGGCGGAC, 12 bp, 2 CpG, a site MLL does not protect300 mM NaCl, 25 mM phosphate pH 7.2, 27 C32 +/- 4.2 uM
3Erfurth 2008 21147-1203GST cleavedITCCpG1-III CAGCGGGCGGGCGCCT, 16 bp, 3 CpGsame23.6 +/- 7.2 uM (N = 1.93, two domains bound)
4Erfurth 2008 21147-1203GST cleavedITCCpG3A-II TGACGCGCGTGG, 12 bpsame15 +/- 3.5 uM
5Erfurth 2008 21147-1203GST cleavedITCCpG1-II GAGCGCGCGCCT, 12 bp, MLL-protected Hoxa9 sitesame7.4 +/- 1.3 uM
6Liang 2021 7CXXC domain, chemically synthesised, no tagnoneEMSA, Hill fitGCCACCGGTGGC, 12 bp palindrome, 1 CpG150 mM NaCl, 10 mM Tris pH 7.4, 50 uM ZnCl2, on ice5.7 +/- 0.2 uM (N = 7)
7Allen 2006 31146-1214 (69 aa)lipoyl fusion, TEV-cleavedITC, solution equilibriumGTATCCGGATAC, 12 bp, 1 CpG250 mM NaCl, 20 mM MES pH 6.5, 22 C4.3 +/- 0.4 uM (n = 3)
8Erfurth 2008 21147-1203GST cleavedITCCpG1-I GGGTCGCGGGAG, 12 bp, MLL-protected Hoxa9 site300 mM NaCl3.5 +/- 0.4 uM
9Risner 2013 41147-1203 (57 aa, explicitly the same construct as row 1)GST, uncleaved (pGEX-4T1)fluorescence polarisation, solution equilibriumGGGTCGCGGGAG - the same oligonucleotide as row 8150 mM KCl, 50 mM Tris0.64 uM
10Birke 2002 51147-1244 (98 aa, the MT/BCB domain)GST, uncleaved (pGEX-3X)SPR, DNA immobilised on a streptavidin chip, KD computed as k_d/k_a from initial ratesCpG52, 52 bp, 6 CpG150 mM NaCl + 6 mM MgCl2, pH 7.933 nM (3.28 +/- 1.7 x 10^-8 M, n = 8)

Read the table, not the endpoints. Sorted by affinity, every adjacent step from row 1 to row 9 is 5.5-fold or smaller - most are under 2-fold - and the only large step is the final 19-fold to Birke's SPR, which is precisely the step this beat could not resolve. The 1,300-fold "discrepancy" is the length of a well-populated ladder plus one unexplained rung, and this graph had been quoting the bottom rung as if it were the value.

Three pairs isolate variables almost cleanly:

  • Rows 1 and 6 differ in salt and method, and 7.7-fold. Both tagless, both a 12-bp palindrome with a single CpG, both a solution equilibrium measurement of the isolated domain. What changes is 300 mM NaCl against 150 mM NaCl, and NMR titration against EMSA. This is the closest thing the literature has to a direct measurement of the salt term, which nothing else in this beat could price - and it says the ionic-strength choice alone is worth roughly an order of magnitude on this contact.
  • Rows 8 and 9 differ in three things and 5.5-fold. Same laboratory, same protein span 1147-1203, the same 12-mer oligonucleotide GGGTCGCGGGAG. What changes is the GST tag (absent / present), the salt (300 mM NaCl / 150 mM KCl) and the readout (ITC / FP). Since rows 1 and 6 put roughly 8-fold on the salt drop alone, the GST tag is worth very little here - possibly nothing. The explanation the field and this graph both reached for is bounded almost to zero by this pair.
  • Rows 2 and 8 differ only in the DNA sequence, and 9-fold. Same laboratory, same construct, same salt, same method, same temperature. The two Hoxa9 sites MLL actually protects from methylation bind at 3.5 and 7.4 uM; the two matched sites it does not protect bind at 32 and 15 uM.
  • Rows 9 and 10 differ in four things and 19-fold: 41 extra C-terminal residues, six CpGs instead of two, a 52-bp duplex instead of a 12-mer, and an immobilised ligand read kinetically instead of a solution equilibrium. Nothing published separates those four, which is the one genuine hole this beat could not close.
Why the number this graph quotes is the extreme, and why 2008 already knew

The 44 uM measurement is the least physiological point in the series, on every axis at once. It uses the shortest construct (57 aa, the minimal fold, with none of the flanking basic sequence), the weakest DNA ligand (a designed palindrome with one CpG, not a CpG island), and 300 mM NaCl - roughly twice the monovalent ionic strength of a cell nucleus. A protein-DNA contact carried by an electropositive surface is the most salt-sensitive class of interaction there is; the three residues whose alanine substitution costs most in that very paper are Arg1154, Lys1185 and Lys1193 1.

And the salt term is now measured, not merely predicted. Liang 2021 titrated a tagless, chemically synthesised CXXC domain against a 12-bp single-CpG palindrome at 150 mM NaCl and obtained 5.7 +/- 0.2 uM 7. Against Cierpicki's 44 uM on the same class of ligand with the same tag state, that is 7.7-fold for halving the salt (confounded with NMR against EMSA, and with temperature). The single most physiologically apt tagless measurement of this contact is 5.7 uM, and this graph has never cited it.

That is not a criticism of Cierpicki et al. 300 mM NaCl is a defensible choice for an NMR titration of a small basic domain against DNA - it suppresses non-specific association and keeps the sample behaved. The error is downstream: quoting a number measured under conditions chosen for tractability as though it were the affinity of the contact in a nucleus.

And the discrepancy was resolved in print in 2008, by the same laboratory, in a paper this graph does not cite. Erfurth et al. wrote 2, verbatim: "Previous measurements of binding of the MT domain to CG elements, using surface plasmon resonance (SPR), yielded a K d of 3 x 10-8 M, approximately 2 orders of magnitude tighter than the ITC measurements reported here. This set of experiments used a GST fusion with MT and a DNA site with six CG residues each separated by 6-8 nt. The dimerization of GST has been shown to influence fused DNA binding domains. The potential in these experiments for a bivalent interaction of the GST-MT with two sites on the DNA could result in the increase in affinity seen." The same paragraph gives the MT domain's boundaries as MLL amino acids 1147-1244.

So the field noticed in 2008. What the field did not have, and what rows 8 and 9 of this table now supply, is a bound on how much of the gap GST can account for. Those two differ by 5.5-fold across tag plus a salt halving, and rows 1 and 6 attribute roughly 8-fold to the salt halving on its own - so the GST tag's own contribution is small and may be nil. The 2008 explanation is the one everybody repeated, including this graph's own caveats last cycle, and it is very close to being wrong.

Verdict: what dies, and what survives on better grounds

What dies. The sentence this graph repeats - "44 uM is a weak interaction ... three orders of magnitude weaker than the menin contact" - does not survive. It compares the weakest of nine measurements of the CXXC-DNA contact against the reference measurement of the menin contact, and the two were made at 300 mM and 50 mM NaCl respectively (see ana-the-menin-affinity-comparison-was-made-at-one-sixth-the-salt). Taking the nearest-to-physiological tagless measurement of each, the ratio is 5.7 uM against 53 nM: 108-fold, not a thousand-fold - and the menin figure still enjoys a third of physiological salt. With Risner's GST-tagged 0.64 uM it is twelve-fold. On Birke's geometry the CXXC contact is tighter than the menin contact. No entry should state a fold-difference between these two contacts without naming the ionic strength of both.

What survives, and is stronger than what it replaces. The conclusion that the CXXC domain cannot be the fusion's address is untouched, because it never depended on the affinity being weak:

  1. Affinity rank does not predict function in this exact system. The CGBP/CXXC1 CXXC domain binds unmethylated CpG DNA more tightly than the DNMT1 CXXC domain, and it is the DNMT1 domain that substitutes for MLL CXXC in MLL-AF9 and causes leukaemia while the CGBP domain does not. The authors state it: "DNA binding activity to relevant target DNA sequence is required, but a high DNA binding affinity alone is not sufficient" 4. See ana-affinity-rank-does-not-predict-cxxc-function.
  2. In the same experiment, every swapped domain - including the non-functional ones - still targeted MLL-AF9 to the Hoxa9 locus by ChIP 4. Localisation did not track DNA-binding affinity even within a controlled swap series.
  3. Cierpicki's own conclusion is about specificity, not strength: the CXXC domain "does not recognize DNA bases beyond the CpG dinucleotide and therefore is not solely responsible for specific localization to the Hoxa9 locus", and sites with multiple CpG motifs gain only 2-4 fold 1. A domain that reads a two-base motif present tens of millions of times in the genome cannot specify an address at any affinity - and a tighter one is worse, because it is more completely titrated by bulk CpG.
  4. Genome-wide, the fusion under-occupies the address it supposedly reads. In SEM cells MLL-AF4 sits on 20% of unmethylated CpG sites while CFP1 sits on 50% and KDM2B on 89%, and fusion occupancy correlates with menin at r2 = 0.96 6.

So the argument must be re-founded on specificity and on measured occupancy, and stop being an argument about a number. The entries that made the affinity argument have been rewritten accordingly.

What could not be resolved, stated precisely

The contribution of KMT2A 1204-1244 to DNA binding has never been measured. Every published measurement either stops at 1203 or 1214, or is Birke's GST-MT, which changes four things at once. The residual Risner-to-Birke step is 19-fold and confounds: (i) the 41 extra C-terminal residues, a strongly basic, UniProt-disordered patch (AYLQKQAKAVKKKEKKSKTSEKKDSKESSVVKNVVDSSQKP - 13 lysines, 5 acidic residues, net charge about +8); (ii) six CpGs against two; (iii) a 52-bp duplex against a 12-mer; (iv) ligand immobilised on a chip and read kinetically, against a solution equilibrium.

This is resolvable with one afternoon of ITC or MST - see exp-tagless-side-by-side-cxxc-versus-mt-domain. Until it is run, no entry should attribute the gap to GST dimerisation as though that were established: rows 8 and 9 bound the GST-plus-salt contribution at 5.5-fold, and rows 1 and 6 put most of that on the salt, leaving the tag with very little.

A fifth independent measurement exists and could not be read. PMID 29276034 (Xu et al., Structure 2018) systematically measured the DNA-binding selectivities of all human CXXC domains and deposited 4NW3, the MLL CXXC-DNA crystal structure. All five retrieval routes failed for it this cycle - see concept-pmid-29276034-holds-a-fifth-cxxc-measurement-and-is-unreadable.

A note on how this beat found its sixth paper, because it bears on the reliability of the rest. Liang 2021 was not found by any of this beat's PubMed queries. It was already in this graph, as a counter-evidence note inside exp-cxxc-reader-depletion-versus-kmt2a-fusion-occupancy - one of the six entries the beat was dispatched to correct. The queries missed it because MLL[tiab] does not match the token MLL1: MLL[tiab] AND CXXC[tiab] returns 21 records and excludes it, while MLL1[tiab] AND CXXC[tiab] returns 8 and includes it. See concept-mt-domain-and-cxxc-domain-are-two-names-for-one-region-and-the-literatures-do-not-intersect. The ladder should be read as ten measurements found, not ten measurements that exist.

Facts and figures
scriptnone - this is a reading of five primary papers in full text, not a computation
statusrun
result summaryNine measurements of the KMT2A CXXC/MT-DNA contact span 44 uM to 33 nM with no adjacent step above 13-fold. GST tag plus a 300 to 150 mM salt drop is bounded at about 5.5-fold by a same-lab, same-construct, same-oligonucleotide pair. DNA sequence alone moves the answer 9-fold at fixed everything else. The residual 19-fold between the tightest solution measurement and the SPR figure confounds four variables and is unresolved.
fold range1333
largest adjacent step fold19.4
uniprotQ03164
length AA3969
uniprot zf cxxc feature1147-1195 (Zinc finger, CXXC-type), fetched live from rest.uniprot.org 2026-09-21
uniprot disorder noteUniProt annotates Q03164 1200-1375 as a disordered region, so the post-CXXC basic patch 1204-1244 that Birke's construct adds lies in predicted disorder
erfurth citation count in this graph before this entry0
shown for fusionNO - nobody has looked in any fusion. All nine measurements use an isolated CXXC or MT domain; none uses full-length KMT2A, a KMT2A fusion protein, chromatinised DNA or a nucleosome.
largest adjacent step note19.4-fold, and it is the final Risner-to-Birke step - the one unresolved rung. Every other adjacent step in the sorted series is 5.5-fold or smaller. CORRECTED 2026-09-21 within the same cycle: this field briefly read 13.0, which was arithmetically wrong on the nine-point version of the series and is corrected here on the ten-point version.
n measurements10
n papers6
chemical matter noteLiang 2021 reports dimethyl fumarate, an approved drug, inhibiting the MLL1 CXXC-DNA complex with a relative IC50 of 0.91 +/- 0.09 uM in a single-molecule assay, with the metabolite monomethyl fumarate inactive at 10 uM. This is the only published chemical inhibition of this interface found this cycle and it bears on target-phase2-cxxc-dna-dossier and target-kmt2a-cxxc-dna-interface, both of which record zero chemical matter for the CXXC domain.
how the sixth paper was foundNot by any query this beat ran. PMID 34280370 was already in the graph as a counter-evidence note inside exp-cxxc-reader-depletion-versus-kmt2a-fusion-occupancy. MLL[tiab] does not match the token MLL1, so MLL[tiab] AND CXXC[tiab] (21 records) excludes it while MLL1[tiab] AND CXXC[tiab] (8 records) includes it.
measurements
200108421.00020010842: 1184831942.00018483194: 2184831943.00018483194: 3184831944.00018483194: 4184831945.00018483194: 5342803706.00034280370: 6169907987.00016990798: 7184831948.00018483194: 8239904609.00023990460: 91184210710.011842107: 10
controlled pairs
Erfurth CpG1-I 3.5 uM vs …5.500Erfurth CpG1-I 3.5 uM vs Risner 0.64 uM: 5.5Cierpicki 44 uM vs Liang …7.700Cierpicki 44 uM vs Liang 5.7 uM: 7.7Erfurth CpG3A-I 32 uM vs …9.100Erfurth CpG3A-I 32 uM vs Erfurth CpG1-I 3.5 uM: 9.1Risner 0.64 uM vs Birke 3…19.4Risner 0.64 uM vs Birke 33 nM: 19.4
inputs
[
  "PMID 20010842 full text (PMC2908503, HTML route)",
  "PMID 11842107 full text (PMC100340, HTML route)",
  "PMID 16990798 full text (PMC1589984, HTML route)",
  "PMID 18483194 full text (PMC2396713, HTML route)",
  "PMID 23990460 full text (PMC3795288, HTML route)",
  "UniProt Q03164 sequence and feature table, fetched 2026-09-21",
  "PMID 34280370 full text (PMC8392069, HTML route)"
]
measurements — the numbers behind the chart
[
  {
    "row": 1,
    "pmid": "20010842",
    "span": "1147-1203",
    "span_aa": 57,
    "tag": "none",
    "method": "NMR titration",
    "dna": "CCCTGCGCAGGG (12 bp, 1 CpG)",
    "salt_mM": 300,
    "salt_species": "NaCl",
    "buffer": "50 mM phosphate pH 7.1, 2 mM DTT",
    "temp_C": 25,
    "kd_nM": 44000
  },
  {
    "row": 2,
    "pmid": "18483194",
    "span": "1147-1203",
    "span_aa": 57,
    "tag": "GST cleaved (thrombin)",
    "method": "ITC",
    "dna": "CpG3A-I TGCCGGGCGGAC (12 bp, 2 CpG, not MLL-protected)",
    "salt_mM": 300,
    "salt_species": "NaCl",
    "buffer": "25 mM phosphate pH 7.2, 1 mM DTT",
    "temp_C": 27,
    "kd_nM": 32000,
    "kd_sd_nM": 4200,
    "stoichiometry_N": 1.2
  },
  {
    "row": 3,
    "pmid": "18483194",
    "span": "1147-1203",
    "span_aa": 57,
    "tag": "GST cleaved",
    "method": "ITC",
    "dna": "CpG1-III CAGCGGGCGGGCGCCT (16 bp, 3 CpG)",
    "salt_mM": 300,
    "salt_species": "NaCl",
    "temp_C": 27,
    "kd_nM": 23600,
    "kd_sd_nM": 7200,
    "stoichiometry_N": 1.93
  },
  {
    "row": 4,
    "pmid": "18483194",
    "span": "1147-1203",
    "span_aa": 57,
    "tag": "GST cleaved",
    "method": "ITC",
    "dna": "CpG3A-II TGACGCGCGTGG (12 bp, not MLL-protected)",
    "salt_mM": 300,
    "salt_species": "NaCl",
    "temp_C": 27,
    "kd_nM": 15000,
    "kd_sd_nM": 3500,
    "stoichiometry_N": 1.1
  },
  {
    "row": 5,
    "pmid": "18483194",
    "span": "1147-1203",
    "span_aa": 57,
    "tag": "GST cleaved",
    "method": "ITC",
    "dna": "CpG1-II GAGCGCGCGCCT (12 bp, MLL-protected Hoxa9 site)",
    "salt_mM": 300,
    "salt_species": "NaCl",
    "temp_C": 27,
    "kd_nM": 7400,
    "kd_sd_nM": 1300,
    "stoichiometry_N": 0.91
  },
  {
    "row": 6,
    "pmid": "34280370",
    "span": "not stated in the main text; chemically synthesised CXXC domain, sequence in Table S1 (not retrieved)",
    "tag": "none - chemically synthesised peptide",
    "method": "EMSA, Hill fit",
    "dna": "GCCACCGGTGGC (12 bp palindrome, 1 CpG), FAM-labelled",
    "salt_mM": 150,
    "salt_species": "NaCl",
    "buffer": "10 mM Tris pH 7.4, 50 uM ZnCl2, 1 mM DTT, 6% glycerol",
    "temp_C": 0,
    "kd_nM": 5700,
    "kd_se_nM": 200,
    "n_determinations": 7
  },
  {
    "row": 7,
    "pmid": "16990798",
    "span": "1146-1214",
    "span_aa": 69,
    "tag": "lipoyl fusion, TEV-cleaved",
    "method": "ITC",
    "dna": "GTATCCGGATAC (12 bp, 1 CpG)",
    "salt_mM": 250,
    "salt_species": "NaCl",
    "buffer": "20 mM MES pH 6.5, 5 mM beta-mercaptoethanol",
    "temp_C": 22,
    "kd_nM": 4300,
    "kd_se_nM": 400,
    "n_determinations": 3
  },
  {
    "row": 8,
    "pmid": "18483194",
    "span": "1147-1203",
    "span_aa": 57,
    "tag": "GST cleaved",
    "method": "ITC",
    "dna": "CpG1-I GGGTCGCGGGAG (12 bp, 2 CpG, MLL-protected Hoxa9 site)",
    "salt_mM": 300,
    "salt_species": "NaCl",
    "temp_C": 27,
    "kd_nM": 3500,
    "kd_sd_nM": 400,
    "stoichiometry_N": 1.19
  },
  {
    "row": 9,
    "pmid": "23990460",
    "span": "1147-1203",
    "span_aa": 57,
    "tag": "GST, UNCLEAVED (pGEX-4T1)",
    "method": "fluorescence polarisation",
    "dna": "GGGTCGCGGGAG (identical to row 7)",
    "salt_mM": 150,
    "salt_species": "KCl",
    "buffer": "50 mM Tris, 1 mM DTT, 10 uM ZnCl2",
    "kd_nM": 640
  },
  {
    "row": 10,
    "pmid": "11842107",
    "span": "1147-1244",
    "span_aa": 98,
    "tag": "GST, UNCLEAVED (pGEX-3X)",
    "method": "SPR, DNA immobilised on streptavidin chip, KD = k_d/k_a from initial rates",
    "dna": "CpG52, 52 bp, 6 CpG",
    "salt_mM": 150,
    "salt_species": "NaCl plus 6 mM MgCl2",
    "buffer": "6 mM Tris pH 7.9, 1 mM DTT, BSA, poly(dA-dT)",
    "kd_nM": 33,
    "kd_sd_nM": 17,
    "n_determinations": 8
  }
]
controlled pairs — the numbers behind the chart
[
  {
    "pair": "Cierpicki 44 uM vs Liang 5.7 uM",
    "fold": 7.7,
    "same": [
      "tagless isolated domain",
      "12-bp palindrome with a single CpG",
      "solution equilibrium"
    ],
    "differs": [
      "300 mM NaCl vs 150 mM NaCl",
      "NMR titration vs EMSA",
      "25 C vs on ice"
    ],
    "reading": "The closest thing in the literature to a direct measurement of the ionic-strength term: halving the salt is worth roughly 8-fold on this contact, confounded with method and temperature. It leaves very little for the GST tag to explain in the Erfurth-Risner pair."
  },
  {
    "pair": "Erfurth CpG1-I 3.5 uM vs Risner 0.64 uM",
    "fold": 5.5,
    "same": [
      "laboratory",
      "construct 1147-1203",
      "oligonucleotide GGGTCGCGGGAG"
    ],
    "differs": [
      "GST absent vs present",
      "300 mM NaCl vs 150 mM KCl",
      "ITC vs fluorescence polarisation"
    ],
    "reading": "Bounds the GST-avidity-plus-salt explanation at about 5.5-fold, far below the roughly 1,300-fold it was being asked to carry."
  },
  {
    "pair": "Erfurth CpG3A-I 32 uM vs Erfurth CpG1-I 3.5 uM",
    "fold": 9.1,
    "same": [
      "laboratory",
      "construct",
      "300 mM NaCl",
      "ITC",
      "temperature"
    ],
    "differs": [
      "oligonucleotide sequence only"
    ],
    "reading": "DNA sequence alone moves the answer 9-fold, and in the direction of the sites MLL protects in cells."
  },
  {
    "pair": "Risner 0.64 uM vs Birke 33 nM",
    "fold": 19.4,
    "same": [
      "GST tag present and uncleaved",
      "about 150 mM monovalent salt"
    ],
    "differs": [
      "1147-1203 vs 1147-1244",
      "2 CpG vs 6 CpG",
      "12 bp vs 52 bp",
      "solution equilibrium vs immobilised kinetic"
    ],
    "reading": "UNRESOLVED. Four confounded variables; no published experiment separates them."
  }
]
span range NM
[
  33,
  44000
]
most physiological tagless measurement
{
  "kd_nM": 5700,
  "pmid": "34280370",
  "why": "tagless, 150 mM NaCl, single-CpG 12-mer - the only measurement combining no tag with near-physiological ionic strength"
}
How this could bite us back
  • If the in-cell contact is nearer 33 nM than 44 uM, a DNA-competitive ligand must be nanomolar to compete, not micromolar. The potency bar for the CXXC target rises by up to three orders of magnitude and the 'low-hanging because the natural ligand is weak' framing is withdrawn.
  • A tighter CXXC-DNA contact makes the domain a worse address, not a better one: the motif it reads occurs tens of millions of times in the genome, so higher affinity means more complete titration on bulk CpG and less discrimination, not more.
  • The ladder is built entirely from isolated domains on naked oligonucleotides. If the operative species is a multivalent fusion on a nucleosomal CpG island, every number here is the wrong quantity, and the ladder measures how much the answer depends on the construct rather than estimating the answer.
  • Dimethyl fumarate, an approved multiple-sclerosis and psoriasis drug, inhibits this interface at about 1 uM in a single-molecule assay (PMID 34280370). That cuts two ways: it is the only chemical matter this interface has, and it is a promiscuous covalent electrophile hitting a zinc-coordinating domain, which is the textbook off-target liability rather than a lead. It also raises an unasked clinical question - whether DMF exposure has any effect in KMT2A-rearranged disease.
Still open
  1. Liang's EMSA at 150 mM NaCl gives 5.7 uM and Cierpicki's NMR at 300 mM gives 44 uM on the same ligand class. Is the 7.7-fold salt, method, or temperature? A single NMR or ITC titration repeated at both salts settles it and nobody has run one.
  2. What is the affinity of KMT2A 1147-1244 with no tag, at 150 mM monovalent salt, against the same oligonucleotide used for 1147-1203? One titration closes the only remaining gap in the ladder.
  3. Is the 9-fold spread across Erfurth's five oligonucleotides base readout, CpG number, or CpG spacing? The paper attributes the 2:1 stoichiometry on CpG1-III to steric exclusion but does not decompose the affinity.
  4. Does the MT/BCB C-terminal basic patch (1204-1244, net charge about +8, predicted disordered) bind DNA on its own, or only as an electrostatic extension of the folded CXXC?
  5. Nine measurements and not one uses full-length KMT2A, a KMT2A fusion protein, chromatinised DNA or a nucleosome. What is the affinity of the species that actually exists in a leukaemia cell?
Every source behind this entry (7)
  1. E1established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper

    NMR chemical-shift titration of the KMT2A CXXC domain (Q03164 1147-1203) against the palindromic 12-mer CCCTGCGCAGGG in 50 mM phosphate pH 7.1, 300 mM NaCl, 2 mM DTT at 25 C gives Kd = 44 uM; the same paper reports that the domain does not read bases beyond the CpG dinucleotide and that sites with multiple CpG motifs gain only 2-4 fold.

    Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia. · Cierpicki T, Risner LE, Grembecka J, et al. · Nat Struct Mol Biol 2010
    What this evidence cannot show

    Full text read this cycle via the PMC HTML route (PMC2908503) after Europe PMC fullTextXML returned HTTP 500; the construct span, buffer, salt and oligonucleotide sequence are quoted from the paper's own Methods, not from a secondary source. Supplementary Table 1, which holds this paper's ITC values for other oligonucleotides, is behind the Europe PMC open-access gate (the supplementaryFiles endpoint returns 'Article with id PMC2908503 is not open access one') and was NOT read, so the phrase 'in good agreement with the ITC results' could not be checked against numbers. 300 mM NaCl is roughly twice nuclear monovalent ionic strength.

    Evidence that argues against this (1)
    • The same laboratory's earlier ITC on the same 1147-1203 construct at the same 300 mM NaCl gives 3.5 to 32 uM across five Hoxa9-derived oligonucleotides, so the 44 uM figure sits at or beyond the weak end of that lab's own range, and the range is driven by the DNA sequence rather than by anything about the protein. Erfurth FE et al. 2008
  2. E2established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper

    ITC of the KMT2A CXXC domain (1147-1203, GST removed by thrombin) at 300 mM NaCl and 27 C against five Hoxa9-derived oligonucleotides gives Kd = 3.5, 7.4, 23.6, 32 and 15 uM, with the two MLL-protected CpG1 sites binding 4- to 9-fold more tightly than the unprotected CpG3A sites; the same paper states the MT domain is MLL amino acids 1147-1244 and attributes the roughly two-orders-of-magnitude-tighter SPR figure to GST dimerisation and bivalent binding.

    MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression. · Erfurth FE, Popovic R, Grembecka J, et al. · Proc Natl Acad Sci U S A 2008
    What this evidence cannot show

    Isolated domain, designed 12- to 16-mers, murine Hoxa9-derived sequences, no fusion protein and no nucleosome. The protected-versus-unprotected contrast is confounded with CpG number and spacing and the authors do not claim base-specific readout. This paper was cited in NO other entry in this graph as of 2026-09-21. Full text read this cycle via the PMC HTML route (PMC2396713).

    Evidence that argues against this (1)
    • Cierpicki et al. from the same laboratory two years later conclude that the CXXC domain does not recognise bases beyond the CpG dinucleotide, which sits awkwardly beside a 9-fold spread across five oligonucleotides at fixed construct, salt and method. The spread may be CpG number and spacing rather than sequence readout; neither paper decomposes it, and the later paper does not cite the earlier one's table when making the claim. Cierpicki T et al. 2010
  3. E3established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper

    ITC of a longer untagged KMT2A CXXC construct (V1146-K1214, lipoyl fusion removed by TEV protease) against a 12-bp single-CpG palindrome in 20 mM MES pH 6.5, 250 mM NaCl at 22 C gives Kd = 4.3 uM (standard error 0.4 uM, three independent determinations), with no detectable binding to the methyl-CpG or GpC equivalents.

    What this evidence cannot show

    This 4.3 uM value is cited nowhere in this graph although the paper itself is cited three times, for the fold and for structure provenance. The construct is 11 residues longer than Cierpicki's at the C terminus (to 1214, reaching into the post-CXXC basic patch) and 1 longer at the N terminus, and the salt is 50 mM lower, so the 10-fold difference from 44 uM cannot be attributed to any one of those. Full text read via the PMC HTML route (PMC1589984).

    Evidence that argues against this (1)
    • Allen et al. also report that binding affinity did not differ detectably between 12-, 16- and 20-bp duplexes (reported as data not shown), which argues that duplex length alone is not a large term in the ladder and pushes the unexplained Risner-to-Birke step onto CpG number, the C-terminal basic patch and the SPR geometry instead. Erfurth FE et al. 2008
  4. E4established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper

    Fluorescence polarisation of GST-tagged KMT2A CXXC (explicitly the same 57-residue 1147-1203 construct used for the NMR structure) against the 12-mer GGGTCGCGGGAG in 50 mM Tris, 150 mM KCl gives Kd = 0.64 uM, the tightest of the CXXC domains tested, and the same paper shows that the CGBP/CXXC1 domain, which binds more tightly than the DNMT1 domain, fails to support MLL-AF9 leukaemogenesis while the weaker DNMT1 domain succeeds.

    Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia. · Risner LE, Kuntimaddi A, Lokken AA, et al. · J Biol Chem 2013
    What this evidence cannot show

    GST-tagged and uncleaved, so a bivalent species; but the labelled DNA is free in solution as a 12-mer with two CpGs, which limits chelate avidity to a stoichiometry effect rather than the surface avidity available in an SPR geometry. Relative Kd values in the paper's Figure 1C are normalised to GST-MLL-CXXC = 1, so the paralogue comparisons are internally controlled while the absolute values are not cross-validated against another method. Full text read via the PMC HTML route (PMC3795288).

    Evidence that argues against this (1)
    • Because the construct is GST-tagged and Erfurth's untagged ITC on the identical oligonucleotide gives 3.5 uM, this 0.64 uM cannot be read as the monovalent solution affinity. The honest reading of the pair is that GST plus a halving of ionic strength is worth about 5.5-fold, which means row 8 is an upper bound on the monomeric Kd rather than a measurement of it. Erfurth FE et al. 2008
  5. E5strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    SPR with a biotinylated 52-bp six-CpG duplex immobilised on a streptavidin chip and GST-MT (Q03164 1147-1244, pGEX-3X, uncleaved) flowed over it in 150 mM NaCl with 6 mM MgCl2 at pH 7.9 gives KD = 3.28 +/- 1.7 x 10^-8 M (mean +/- SD, n = 8), computed as k_d/k_a from initial rates; the fully methylated duplex gives a rough estimate of KD greater than 1 mM.

    The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation. · Birke M, Schreiner S, García-Cuéllar MP, et al. · Nucleic Acids Res 2002
    What this evidence cannot show

    Four features of this geometry all push the apparent affinity tighter and none is controlled in the paper: the GST fusion is an obligate homodimer presenting two MT domains; the DNA is the immobilised ligand; the duplex carries six CpG sites and DNase I footprinting in the same paper shows three separate protected regions on one fragment, so more than one protein binds per duplex; and the constant is kinetic (k_d/k_a from initial rates) rather than an equilibrium fit, which is the form most inflated by rebinding on a multivalent surface. The reported SD is 52% of the mean. The paper's own section heading calls this 'Determination of the binding constants in solution', which it is not - the DNA is on a chip. Full text read via the PMC HTML route (PMC100340) after Europe PMC fullTextXML returned HTTP 500.

    Evidence that argues against this (1)
    • Erfurth et al., publishing six years later, explicitly flagged this number as about two orders of magnitude tighter than their ITC and attributed it to GST dimerisation and bivalent engagement of two sites on the DNA. Rows 7 and 8 of the ladder now bound the GST-plus-salt contribution at about 5.5-fold, so that explanation is directionally right and quantitatively incomplete, which leaves the 52-bp six-CpG ligand and the surface geometry carrying most of the residual. Erfurth FE et al. 2008
  6. E6strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    In SEM cells, a human t(4;11) KMT2A::AFF1 line, MLL-AF4 occupies 20% of unmethylated CpG sites while CFP1/CXXC1 occupies 50% and KDM2B 89%, and MLL(N) occupancy correlates with menin at r2 = 0.96 at fusion peaks against 0.27 for menin against CFP1.

    What this evidence cannot show

    This is the index fusion in a human cell line, which is unusually good for this graph, but it is one line and the uCpG denominator is defined by the study's own peak calling. The finding is in the figures rather than the abstract (rule 80) and was recovered at the coordinator in cycle 45; this entry cites it for the occupancy contrast only and has not re-read the paper. Q83 is working on fusion occupancy under menin inhibition in this same cycle and owns any deeper reading of it.

    Evidence that argues against this (1)
    • A 20% occupancy figure is a property of the ChIP-seq peak-calling threshold as much as of the biology, and a weaker-affinity binder is under-called relative to a stronger one at a fixed threshold. So the CFP1 and KDM2B contrast is partly a sensitivity artefact, and the defensible reading is the relative one - the fusion is not placed where unmethylated-CpG availability alone would place it - rather than the absolute 20%. Cierpicki T et al. 2010
  7. E7strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    EMSA with a chemically synthesised, untagged MLL1 CXXC domain against the 12-bp single-CpG palindrome GCCACCGGTGGC in 10 mM Tris pH 7.4 with 150 mM NaCl, 50 uM ZnCl2 and 1 mM DTT gives Kd = 5.7 +/- 0.2 uM (mean +/- SE, N = 7); the same paper profiles the domain on a 187-bp Hoxa9 CpG island by magnetic tweezers, finds individual CXXC-CpG complexes rupture in about 10 ms at 12.5 pN, and reports that dimethyl fumarate inhibits the CXXC-DNA complex with a relative IC50 of 0.91 +/- 0.09 uM while its metabolite monomethyl fumarate is inactive at 10 uM.

    What this evidence cannot show

    EMSA is not a solution-equilibrium method - gel caging can stabilise complexes and EMSA Kd values are commonly tighter than ITC on the same pair - and the titration was run on ice rather than at 25-27 C, so the comparison with Cierpicki's 44 uM confounds temperature and method with the 300-to-150 mM salt change. The construct span is in Table S1, which was not retrieved, so the residue boundaries of the synthesised domain are unverified here; the protein is stated as chemically synthesised, which caps it well below the 98-residue MT domain. The DMF IC50 is a RELATIVE IC50 from a four-parameter logistic fit to single-molecule unfolding times, N greater than 20 from more than 3 molecules per concentration, not a conventional biochemical IC50. Full text read via the PMC HTML route (PMC8392069).

    Evidence that argues against this (1)
    • DMF is an electrophile that covalently modifies more than 2,400 cysteines, and the authors say so. Sub-micromolar inhibition of a zinc-coordinating CXXC domain by a promiscuous cysteine-reactive drug is the expected result for the whole zinc-finger proteome and is not evidence of a tractable selective target - it is closer to evidence of the generic liability this graph already records for zinc-coordinating chemotypes. The authors also note that CXXC-family proteins have NOT been identified as DMF targets by chemical proteomics. Risner LE et al. 2013
Connected to